深圳瑞华泰薄膜科技股份有限公司独立董事 关于公司第二届董事会第十四次会议相关事项的独立意见 根据《中华人民共和国公司法》（以下简称"《公司法》"）《中华人民共和 国证券法》《上市公司独立董事规则》《上海证券交易所科创板股票上市规则》等 法律、法规、规范性文件及《深圳瑞华泰薄膜科技股份有限公司章程》（以下简 称"《公司章程》"）的有关规定，作为深圳瑞华泰薄膜科技股份有限公司（以 下简称"公司"）的独立董事，我们认真审阅了公司第二届董事会第十四次会议 资料后，基于独立客观判断立场，本着审慎负责的态度，现就以下相关事项发表 如下独立意见： 一、《关于公司 2023 年半年度募集资金存放与使用情况专项报告的议案》的 独立意见 公司 2023 年半年度募集资金存放与使用情况符合《上市公司监管指引第 2 号——上市公司募集资金管理和使用的监管要求》《上海证券交易所科创板上市 公司自律监管指引第 1 号——规范运作》《上海证券交易所科创板股票上市规则》 等法律法规、规范性文件的相关规定，符合公司《募集资金管理制度》的规定， 对募集资金进行了专户存储和专项使用，并及时履行了相关信息披露义务，募集 资金具体使用情况与公司已披露 ...

| 证券代码：688323 | 证券简称：瑞华泰 | 公告编号：2023-039 | | --- | --- | --- | | 转债代码：118018 | 转债简称：瑞科转债 | | 深圳瑞华泰薄膜科技股份有限公司关于 使用部分暂时闲置募集资金进行现金管理的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 深圳瑞华泰薄膜科技股份有限公司（以下简称"公司"或"瑞华泰"）于 2023 年 8 月 18 日召开了第二届董事会第十四次会议和第二届监事会第十次会议，审 议通过《关于使用部分暂时闲置募集资金进行现金管理的议案》，同意公司在不 影响募集资金投资计划正常进行的前提下，使用额度不超过人民币 6,000 万元（含 本数）的暂时闲置募集资金进行现金管理，用于安全性高、流动性好的理财产品 或存款类产品（包括但不限于保本型理财产品、结构性存款、定期存款、大额存 单、通知存款等），且该等现金管理产品不得用于质押，不用于以证券投资为目 的的投资行为，使用期限自董事会审议通过之日起 12 个月内有效，在前述额度 及使 ...

| | | 深圳瑞华泰薄膜科技股份有限公司 2023 年半年度募集资金存放及使用情况专项报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 根据《上市公司监管指引第 2 号——上市公司募集资金管理和使用的监管 要求》《上海证券交易所上市公司自律监管指引第 1 号——规范运作》和《上 海证券交易所科创板股票上市规则》等有关规定，深圳瑞华泰薄膜科技股份有 限公司（以下简称"公司"或"深圳瑞华泰"）2023 年半年度募集资金存放与 使用情况说明如下： 一、募集资金基本情况 (一)实际募集资金金额和资金到账时间 1、2021 年首次公开发行股票 根据中国证券监督管理委员会于 2021 年 3 月 16 日出具的《关于同意深圳 瑞华泰薄膜科技股份有限公司首次公开发行股票注册的批复》（证监许可〔2021〕 841 号），公司首次向社会公开发行人民币普通股 4,500 万股，发行价格为每股 人民币 5.97 元，募集资金总额为人民币 26,865.00 万元，扣除发行费用后实际 募集资金净额为人民币 21,831.91 万元。上述募集 ...

深圳瑞华泰薄膜科技股份有限公司 第二届监事会第十次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 | 证券代码：688323 | 证券简称：瑞华泰 | 公告编号：2023-037 | | --- | --- | --- | | 转债代码：118018 | 转债简称：瑞科转债 | | 表决结果：同意 3 票，反对 0 票，弃权 0 票。 具体内容详见公司于同日在上海证券交易所网站（www.sse.com.cn）披露的 《深圳瑞华泰薄膜科技股份有限公司 2023 年半年度报告》《深圳瑞华泰薄膜科技 股份有限公司 2023 年半年度报告摘要》。 （二） 审议通过《关于公司 2023 年半年度募集资金存放与使用情况专项报 告的议案》 一、监事会会议召开情况 深圳瑞华泰薄膜科技股份有限公司（以下简称"公司"）第二届监事会第十 次会议于 2023 年 8 月 8 日以电子邮件方式发出了本次会议的召开通知，于 2023 年 8 月 18 日以现场方式召开。本次会议应出席的监事 3 名，实际出席的监事 3 名，会议由公司监事 ...

| 证券代码：688323 | 证券简称：瑞华泰 | 公告编号：2023-036 | | --- | --- | --- | | 转债代码：118018 | 转债简称：瑞科转债 | | 深圳瑞华泰薄膜科技股份有限公司 关于"瑞科转债"2023 年付息的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 深圳瑞华泰薄膜科技股份有限公司(以下简称"公司")于 2022 年 8 月 18 日向不特定对象发行可转换公司债券（以下简称"瑞科转债"或"可转债"）将 于 2023 年 8 月 18 日开始支付自 2022 年 8 月 18 日至 2023 年 8 月 17 日期间的利 息。根据公司《深圳瑞华泰薄膜科技股份有限公司 2022 年度向不特定对象发行 可转换公司债券募集说明书》（以下简称"《募集说明书》"）有关条款的规定，现 将有关事项公告如下： 一、可转债发行上市概况 1 可转债付息债权登记日：2023 年 8 月 17 日 可转债除息日：2023 年 8 月 18 日 可转债兑息日: 2023 年 8 月 ...

Financial Performance - The company's operating revenue for Q1 2023 was ¥44,707,484.37, representing a decrease of 44.66% compared to the same period last year[5] - The net profit attributable to shareholders was -¥7,603,816.40, a decline of 161.91% year-over-year[5] - The net profit attributable to shareholders after deducting non-recurring gains and losses was -¥8,344,690.15, down 171.11% from the previous year[5] - The basic and diluted earnings per share were both -¥0.04, reflecting a decrease of 157.14% compared to the same period last year[6] - The company experienced a significant decline in revenue due to a contraction in the global consumer electronics market and inventory adjustments by downstream customers[8] - Net profit for Q1 2023 was a loss of ¥7,603,816.40, compared to a profit of ¥12,281,757.37 in Q1 2022, representing a significant decline[18] - Operating profit for Q1 2023 was a loss of ¥7,609,318.89, compared to a profit of ¥13,782,270.81 in Q1 2022[17] - Basic and diluted earnings per share for Q1 2023 were both -¥0.04, compared to ¥0.07 in Q1 2022[18] Cash Flow and Liquidity - The net cash flow from operating activities was ¥15,722,523.14, an increase of 7.81% year-over-year[6] - In Q1 2023, the cash inflow from operating activities was CNY 65,669,159.94, an increase of 14.8% compared to CNY 57,530,668.09 in Q1 2022[21] - The net cash flow from operating activities was CNY 15,722,523.14, up from CNY 14,583,791.57 in the same period last year[21] - Cash outflow for investing activities was CNY 40,001,830.48, significantly lower than CNY 103,553,542.04 in Q1 2022[22] - The net cash flow from investing activities was -CNY 40,001,830.48, compared to -CNY 103,553,542.04 in the previous year[22] - The net cash flow from financing activities was -CNY 22,687,554.06, a decrease from CNY 29,743,127.36 in Q1 2022[22] - The total cash and cash equivalents at the end of Q1 2023 were CNY 222,090,678.39, up from CNY 128,144,587.89 at the end of Q1 2022[22] - The company experienced a net decrease in cash and cash equivalents of CNY 46,962,705.79 in Q1 2023, compared to a decrease of CNY 59,118,028.33 in Q1 2022[22] Assets and Liabilities - Total assets at the end of the reporting period were ¥2,302,740,448.35, a decrease of 0.60% from the end of the previous year[6] - The company's current assets totaled RMB 441,088,611.46, down from RMB 482,929,354.12 at the end of 2022, indicating a decrease of approximately 8.7%[14] - Cash and cash equivalents were reported at RMB 223,776,975.03, a decrease of 17.3% from RMB 270,746,346.38 at the end of 2022[13] - Accounts receivable decreased to RMB 62,216,347.56 from RMB 71,203,984.13, reflecting a decline of about 12.8%[13] - Inventory increased to RMB 80,937,182.86, up from RMB 68,992,323.98, representing a growth of approximately 17.3%[14] - Non-current assets totaled RMB 1,861,651,836.89, slightly up from RMB 1,833,677,224.18, indicating a growth of about 1.5%[14] - The total liabilities as of Q1 2023 were ¥1,278,779,469.55, slightly down from ¥1,285,043,936.58 in Q1 2022[17] - The total equity attributable to shareholders was ¥1,023,960,978.80 in Q1 2023, compared to ¥1,031,562,641.72 in Q1 2022[17] Research and Development - Research and development expenses totaled ¥7,694,653.55, which is 17.21% of operating revenue, an increase of 9.48 percentage points from the previous year[6] - Research and development expenses increased to ¥7,694,653.55 in Q1 2023, up from ¥6,242,951.26 in Q1 2022, indicating a focus on innovation[17] - The company plans to continue focusing on R&D and product development to improve its market position despite current challenges[8] Other Information - The company has not disclosed any new product developments or market expansion strategies in the current report[12] - The company reported a credit impairment loss of ¥471,387.07 in Q1 2023, compared to a gain of -¥96,764.88 in Q1 2022[17] - The cash flow statement for Q1 2023 indicates ongoing financial challenges, with further details to be analyzed[20]

Financial Performance - The company plans to distribute a cash dividend of 0.70 RMB per 10 shares, totaling 12,600,000 RMB, which accounts for 32.41% of the net profit attributable to shareholders for 2022[6]. - The company has not achieved profitability since its listing, indicating ongoing financial challenges[4]. - In 2022, the company's operating revenue was CNY 301.71 million, a decrease of 5.36% compared to CNY 318.82 million in 2021[22]. - The net profit attributable to shareholders was CNY 38.87 million, down 30.64% from CNY 56.05 million in the previous year[22]. - The net profit after deducting non-recurring gains and losses was CNY 29.19 million, a decline of 42.68% from CNY 50.93 million in 2021[22]. - The basic earnings per share decreased by 35.29% to CNY 0.22 from CNY 0.34 in 2021[23]. - The comprehensive gross profit margin for 2022 was 38.24%, a decrease of 6.62 percentage points year-on-year, mainly due to rising raw material procurement prices and electricity costs[98]. - The company's operating revenue for the reporting period was CNY 301.71 million, a decrease of 5.36% compared to the previous year[96]. - Net profit attributable to the parent company was CNY 38.87 million, down 30.64% year-on-year, while the net profit after deducting non-recurring gains and losses was CNY 29.19 million, a decline of 42.68%[96]. Operational Risks and Governance - The company has outlined various operational risks in the report, which investors should consider[4]. - The report includes a forward-looking statement risk declaration, cautioning investors about potential risks[7]. - The company does not have any non-operating fund occupation by controlling shareholders or related parties[8]. - There are no violations of decision-making procedures regarding external guarantees[9]. - The company has not disclosed any special arrangements for corporate governance[7]. - The annual report received a standard unqualified audit opinion from Da Xin Accounting Firm[5]. - The company emphasizes compliance with information disclosure regulations and has implemented measures to prevent insider trading[38]. - The company has established a subsidiary management system to enhance operational management and protect the rights of investors[195]. - The internal control system has been effective, with no significant deficiencies reported during the reporting period[195]. Research and Development - Research and development expenses accounted for 8.96% of operating revenue, an increase of 0.62 percentage points compared to 8.34% in 2021[23]. - The company is focusing on R&D in high-performance polyimide materials for flexible displays, new energy, integrated circuit packaging, and aerospace applications[32]. - The company has developed a complete set of core technologies for high-performance PI films, including formulation, process, and equipment, becoming one of the largest manufacturers in China with the most diverse product offerings in the global market[53]. - The company has established a comprehensive technical innovation platform to enhance its R&D capabilities and product offerings in response to market needs[126]. - The company has developed a proprietary technology for the synthesis of PAA resin, ensuring stability and consistency in production[63]. - The company is expanding its research into flexible perovskite solar cells, aiming to commercialize production techniques for larger devices[71]. - The company has developed a flexible transparent T-type film with a transmittance rate of over 88% and a bending resistance of over 400℃, indicating strong performance in OLED applications[71]. - The number of R&D personnel increased to 89, representing 19.82% of the total workforce, up from 73 and 19.78% in the previous period[73]. Market Position and Strategy - The company specializes in the R&D, production, and sales of high-performance PI films, with key products including thermal control PI films, electronic PI films, and electrical PI films, filling domestic gaps and gaining recognition from major companies like Siemens and Bombardier[39]. - The company has established itself as a key player in the high-performance PI film market, which is critical for the development of high-tech industries in China, with a strong focus on independent R&D and innovation[49]. - The company is positioned favorably in the high-performance PI film industry due to supportive national policies and its independent technological capabilities[121]. - The company is targeting four emerging application areas for PI materials: high-speed communication, flexible displays, integrated circuit packaging, and clean energy[143][144]. - The company plans to increase its production capacity of high-performance PI films by 1,600 tons, which poses a risk of underutilization if market conditions change unfavorably[94]. - The company is actively pursuing new product development and technological advancements to enhance market competitiveness[170]. Financial Management and Investments - The company has short-term borrowings of CNY 35 million and long-term borrowings of CNY 747.3 million, indicating significant debt levels[90]. - The accounts receivable balance at the end of the reporting period was CNY 75.04 million, with a bad debt provision of CNY 3.84 million, representing a 5.12% provision rate[90]. - The company has stable supplier relationships, with no single supplier accounting for over 50% of total purchases, indicating a diversified supply chain[113]. - The company has committed to not diluting immediate returns from the convertible bond issuance, ensuring protection for existing shareholders[170]. - The company plans to use part of the temporarily idle raised funds for cash management, optimizing capital allocation[170]. - The company has established a strategic committee to guide long-term planning and market expansion initiatives[173]. Employee and Governance Structure - The company employed a total of 449 staff, with 308 in the parent company and 141 in major subsidiaries[180]. - The company’s employee composition includes 191 production staff, 89 technical staff, and 16 sales staff, among others[180]. - The company has a significant number of core technical personnel, with total compensation for this group reaching 3,000,000, indicating a focus on retaining technical talent[157]. - The company has a focus on technological advancement, as indicated by the presence of multiple core technical personnel with significant experience in the field[157]. - The company has maintained a stable governance framework, ensuring the legality and effectiveness of its meeting resolutions[150]. - The company held 2 shareholder meetings, 9 board meetings, and 8 supervisory board meetings in 2022, all in compliance with legal and regulatory requirements[150]. Environmental Responsibility - The company has committed to environmental responsibility as part of its corporate governance strategy[197]. - In 2022, the company invested 10.59 million yuan in environmental protection initiatives[200]. - The company emphasizes technology innovation and quality, aiming for high customer satisfaction while ensuring safety and environmental responsibility[198]. - The company has implemented a series of information disclosure management systems to enhance transparency and protect shareholder interests[199].

会议召开时间：2023 年 3 月 22 日(星期三)下午 15:00-16:00 会议召开地点： 上 海 证 券 交 易 所 上 证 路 演 中 心 （ 网 址 ： http://roadshow.sseinfo.com/） 会议召开方式：网络文字互动 投资者可于 2023 年 3 月 15 日(星期三)至 3 月 21 日(星期二)16:00 前登 录上证路演中心网站首页点击"提问预征集"栏目或通过公司邮箱 ir@rayitek.cn 进行提问。公司将在说明会上对投资者普遍关注的问题进行回答。 | 证券代码：688323 | 证券简称：瑞华泰 | 公告编号：2023-011 | | --- | --- | --- | | 转债代码：118018 | 转债简称：瑞科转债 | | 深圳瑞华泰薄膜科技股份有限公司 关于召开 2022 年年度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 深圳瑞华泰薄膜科技股份有限公司（以下简称"公司"）拟于 2023 年 3 月 18 日在上海证券交易所网站 ...

编号：2022-01 投资者关系活动汇总表 证券代码：688323 证券简称：瑞华泰 深圳瑞华泰薄膜科技股份有限公司 机构投资者调研活动汇总表 | --- | --- | --- | |-----------------------|----------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------| | | | | | | | 特定对象调研 口分析师会议 | | 投资者活动 | 口媒体采访 口业绩说明会 | | | 类别 | 口新闻发布会 口路演活动 | | | | 现场参观 口其他 | | | 参与单位 名称 | 和资管 | 国海证券、广发基金、鹏华基金、翎展投资、中泓汇富、方瑞天成投资、慧 | | 时间 | 2022 年 5 月 12 日、 5 | 月 13 日、 5 月 19 日、 5 月 20 日 | | 地点 | 公 ...

2022 年第三季度报告 证券代码：688323 证券简称：瑞华泰 债券代码：118018 债券简称：瑞科转债 深圳瑞华泰薄膜科技股份有限公司 2022 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整， 不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中财务 信息的真实、准确、完整。 第三季度财务报表是否经审计 □是 √否 一、 主要财务数据 (一)主要会计数据和财务指标 单位：元 币种：人民币 | 项目 | 本报告期 | 本报告期 比上年同 | | 年初至报告期 末比上年同期 | | --- | --- | --- | --- | --- | | | | 期增减变 | 年初至报告期末 | 增减变动幅度 | | | | 动幅度(%) | | (%) | | 营业收入 | 61,273,852.34 | -25.71 | ...